FRANKLIN LAKES, N.J., July 12, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company's 2020 Sustainability Goals .

BD's sustainability strategy is driven by its purpose - advancing the world of health - and focuses on four priorities:

    --  Innovation - health care safety, reach and cost
    --  Access - health care in resource-limited populations
    --  Efficiency - environmentally sound products and resilient operations
    --  Empowerment - positive workforce and community impacts

Highlights from this year's progress report include:

    --  Innovation - Through technology, processes, systems and partnerships, BD
        continues to pioneer new, relevant ways to impact the quality of care
        for both customers and health care systems, including redefining
        medication management technologies; identifying the tools needed to
        support disease diagnosis and treatment; as well as developing new
        technologies that provide more advanced "wearable" drug delivery devices
        and diabetes management applications.
    --  Access - As a leader in areas that are critical to the future of medical
        technology and society as a whole, BD continues to expand health care
        access to vulnerable populations through partnerships with leading
        organizations and governments, including the U.S. Agency for
        International Development, The U.S. President's Emergency Plan for AIDS
        Relief, and the Centers for Disease Control and Prevention.
        Additionally, the company has placed a strong focus on antimicrobial
        resistance (AMR). Through global mobilization, collaboration, education
        and training, BD is working towards infection prevention, diagnostics
        and surveillance solutions that strengthen health systems and combat AMR
        in both the developed and under-resourced areas of the world.
    --  Efficiency - BD continues to take action and establish partnerships that
        address some of the world's most pressing environmental challenges, such
        as climate change and natural resource scarcity. Currently, 98 percent
        of BD's electric power used by operations in the U.S. and 66 percent of
        global electric power consumption is obtained from renewable resources.
    --  Empowerment - As an organization that employs more than 65,000
        associates across six continents, BD values an inclusive and diverse
        workforce that reflects the communities, customers and patients that it
        serves. The company has made strides towards its 2020 Sustainability
        Goals, particularly in the areas of diverse hiring, employee engagement
        and leadership development. Notably, this year, BD launched a Global
        Inclusion Council compromised of highly influential, next generation
        leaders to facilitate action, and drive change from within and across
        the company.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

Contact:
Jessica Offerjost
BD Public Relations
(201) 847-5297
jessica.offerjost@bd.com

Monique N. Dolecki
BD Investor Relations
201.847.5378
Monique_Dolecki@bd.com

View original content with multimedia:http://www.prnewswire.com/news-releases/bd-shares-progress-towards-achieving-2020-sustainability-goals-300679847.html

SOURCE BD (Becton, Dickinson and Company)